Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma

1 Jul 1997

Abstract excerpt

The prognostic significance of Bcl-2 protein expression and bcl-2 gene rearrangement in diffuse large cell lymphomas (DLCL) is controversial. Bcl-2 protein expression prevents apoptosis and may have an important role in clinical drug resistance. The presence of a bcl-2 gene rearrangement in de novo DLCL suggests a possible follicle center cell origin and perhaps a distinct clinical behavior more akin to low-grade...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Cutaneous lymphoproliferative disorders research
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9207459
DOI: 10.1182/blood.v90.1.244

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's LymphomaPMID 9207459Read ↗

Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's LymphomaSemantic proximity Read ↗

Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases.Semantic proximity Read ↗

Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach.Semantic proximity Read ↗

Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.Semantic proximity Read ↗

MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.Semantic proximity Read ↗

Causes and Consequences ofBCL2Overexpression in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphomaSemantic proximity Read ↗

Incidence and Clinical Significance of Bcl-2 / IgH Rearrangements in Follicular LymphomaSemantic proximity Read ↗

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survivalSemantic proximity Read ↗

Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOPSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.